CHSU Discovery

Abstract

Cannabis potency has increased significantly over the past decade, with parallel rises in adolescent use. High-potency cannabis has been associated with earlier onset of psychosis and increased risk of progression to chronic psychotic disorders. Distinguishing cannabis-induced psychotic disorder (CIPD) from early-onset schizophrenia (EOS) in adolescents remains clinically challenging, particularly in individuals with genetic vulnerability. Disparities in mental health diagnosis and treatment, including delayed access to care and diagnostic bias, may further complicate evaluation and management in minority youth.